We're excited to announce that Health Canada has approved the following mobility and joint health claims for Promentum™ Calcium Fructoborate in Canada at the recommended daily serving of 216 mg:

• It helps to improve/increase mobility in persons suffering from knee discomfort.

• It helps to relieve/reduce joint pain and stiffness in persons suffering from knee discomfort.

We’re committed to providing international value for our partners in their healthy aging, joint health, and mobility products.

Read our full press release to learn more.

‍

FutureCeuticals is excited to announce the celebration of its 25^th anniversary. Since our beginning, we have strived to live out our purpose to help people thrive by bringing nature and science together to unlock the synergistic power of plants.

FutureCeuticals, a sister company to Van Drunen Farms, was founded in 1999 by Jeff Van Drunen, a visionary with a passion for discovering and delivering the nutritional and functional benefits of plants in a convenient and accessible way.

This new company would focus on developing research and products for the emerging nutraceutical and functional food and beverage categories. Over the years, the company grew from a modest ingredient offering to a robust portfolio of branded and clinically researched ingredient solutions with over 250 published articles and patents.

Today, we are proud to be a part of the success of so many partners in the dietary supplement, functional food, and beverage space. We have valued our customers’ support, feedback, and loyalty over the years – they are truly who we celebrate!  

With that, we want to thank our team members, community partners, and customers for an exciting 25 years of innovation and partnership. We are looking forward to what the next 25 years will bring as we continue focusing on plant discovery and research that drives us to create groundbreaking, nutritious, and convenient ingredient solutions from fruits and vegetables for our partners. Let’s Discover What’s Possible™!

A new human study, conducted at Auburn University, directly links a single 200mg dose of CognatiQ®️ to significant improvements in cognitive performance and working memory just one hour post-ingestion.

This study further substantiates CognatiQ®️ as a breakthrough ingredient in brain health supplementation and opens doors to meaningful innovations in the industry.

To learn more, read the full press release.

We are honored and thrilled to announce that CognatiQ® has been selected as the 2023 Nutrition Industry Executive (NIE) New Ingredient Awards Winner in the Condition Specific category!

Congratulations to our team, who has worked very hard on this standout ingredient – and thank you to the judges and NIE for your consideration!

The industry continues to recognize CognatiQ as an outstanding product in the cognitive function category. To learn more about what makes it unique, visit our cognatiQ page futureceuticals.com/cognatiq.

Read more about why the judges selected CognatiQ® on page 52 of NIE’s October/November publication.

We’re thrilled to announce that CognatiQ® has been selected as the Ingredient of the Year in the Cognitive Function category of the 2023 NutraIngredients-USA Awards! Thank you to the judges and to NutraIngredients-USA for this honor!

This is a very special achievement for a very special ingredient! Learn more about what makes CognatiQ® unique at: futureceuticals.com/cognatiq

You can read more about why the judges selected CognatiQ® and the rest of this year’s winners in the NutraIngredients-USA Awards Brochure.